Madrigal Pharmaceuticals, Inc. MDGL Change in AR
Change in AR at other companies
Other financials
Where this comes from
Reported directly by Madrigal Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:IncreaseDecreaseInAccountsReceivable.
The official record: Madrigal Pharmaceuticals, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Madrigal Pharmaceuticals, Inc.'s change in ar.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Madrigal Pharmaceuticals, Inc.'s change in AR?
- Madrigal Pharmaceuticals, Inc. (MDGL) reported change in AR of $52.88M in Q1 2026.
- How has Madrigal Pharmaceuticals, Inc.'s change in AR changed year-over-year?
- Madrigal Pharmaceuticals, Inc.'s change in AR increased by 595.2% year-over-year, from $7.61M to $52.88M.
- What does change in AR mean?
- The change in money owed to the company by its customers.
- How do you interpret change in AR?
- An increase often signals rising sales but can also indicate collection difficulties or deteriorating credit terms.
- How does change in AR compare across companies?
- Analyzed alongside Days Sales Outstanding (DSO) to compare collection efficiency with industry peers.